What is NAGE's pharmaceuticals segment — gross profit?

NAGE (NAGE) reported pharmaceuticals segment — gross profit of $0 in Q1 2026.

What does pharmaceuticals segment — gross profit mean?

Calculated as net sales minus the cost of sales for the pharmaceutical segment. It reflects the basic profitability of the segment's products before accounting for operating expenses. This metric is a key indicator of pricing power and manufacturing cost control.

NAGE NAGE Pharmaceuticals segment — Gross Profit

Other segment segments

Consumer Products segment

$14.82M+5.1%

Ingredients segment

$5.01M-1.2%

Analytical Reference Standards and Services segment

$115K-32.0%

Similar metrics at other companies

OPKPharmaceutical — Gross Profit

$29.71M+22.3%

BAXPharmaceuticals — Segment operating income

$46M-27.0%

MLABBiopharmaceutical Development — Gross Profit

$5.2M-28.3%

ABBVGross Profit

$10.78B+15.4%

VRTXGross Profit

$2.59B+7.8%

PFEGross Profit

$10.9B+0.3%

Other financials

Income statement

See full

Revenue$31.5M+3.3%

Gross profit$20.0M+3.3%

Operating income$1.6M-67.0%

Net income$6.3M+24.8%

EPS (diluted)$0.07+16.7%

Balance sheet

See full

Cash & equivalents$66.5M+19.7%

Total debt$2.6M-26.9%

Total equity$82.3M+48.8%

Total assets$114.3M+40.6%

Cash flow

See full

Operating cash flow-$1.2M-115%

Valuation

See full

Market cap$254.07M-74.9%

Enterprise value$190.09M-79.7%

P/E13.6×-43.5×

P/S2×-6.8×

Profitability

See full

Gross margin64.3%+1.8pp

Operating margin10%-2.2pp

Net margin14.3%+1.2pp

FCF margin-70.4%—

Returns & leverage

See full

Return on equity27.1%-6.4pp

Debt / equity0×0.0×

Current ratio4.6×+0.9×

Where this comes from

Reported directly by NAGE in its filing.

Tagged under the XBRL concept us-gaap:GrossProfit.

The official record: NAGE’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about NAGE's pharmaceuticals segment — gross profit.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NAGE's pharmaceuticals segment — gross profit?: NAGE (NAGE) reported pharmaceuticals segment — gross profit of $0 in Q1 2026.
What does pharmaceuticals segment — gross profit mean?: Calculated as net sales minus the cost of sales for the pharmaceutical segment. It reflects the basic profitability of the segment's products before accounting for operating expenses. This metric is a key indicator of pricing power and manufacturing cost control.